Pinned Tweet
A flagship initiative. Looking forward to the next steps!✍️
Konza Technopolis’s disclosure on the BioPharma Life Sciences Park PPP Project, powering research, innovation & jobs for a healthier tomorrow #SiliconSavannah
133
Apifa Biotech retweeted
Kenya BioVax Institute was pleased to join @apifabiotech and fellow stakeholders in marking @Swedfund International’s support for project preparation and feasibility studies for the proposed Biopharma Life Sciences Park at @KTechnopolis. For us, this is an encouraging step towards building the partnerships, infrastructure and expertise Kenya needs to grow local pharmaceutical and life sciences manufacturing.
As we advance our vaccine and biotherapeutics manufacturing mandate, we welcome opportunities to work with others towards a shared goal: ensuring that more of the health products our communities need can be produced closer to home.
#KenyaBioVax #ApifaBiotech #Swedfund #KonzaTechnopolis #LocalManufacturing #VaccineManufacturing #Biopharma #HealthSecurity #PartnershipsForHealth
Apifa Biotech appreciates Swedfund International for its support in advancing the development of Kenya’s first Biopharma Life Sciences Park.
This partnership is a strong vote of confidence for this project. It brings us closer to realizing a vision that will not only transform Kenya’s pharmaceutical landscape but also strengthen the region’s manufacturing capacity, advance access to essential medicines and biologics, create opportunities for innovation and investment, and contribute to Africa’s health security and self-reliance. #ApifaBiotech.
Apifa Biotech retweeted
.@apifabiotech, a subsidiary of API for Africa (#APIFA) is establishing Kenya’s first #Biopharma Life Sciences #Park at Konza Technopolis.
Structured as a public-private partnership (PPP) between Apifa Biotech and the @TechnopolisKE Development Authority, the project received approval in April 2026 to advance to the development phase, marking a significant step towards establishing a world-class pharmaceutical and life sciences manufacturing hub in Kenya.
Today marks another major milestone, with @Swedfund International, Sweden’s development finance institution, coming on board to support Apifa Biotech fund the project preparation and feasibility studies for the proposed development. This funding commitment provides critical momentum to advance the project, strengthen its investment proposition, and lay the groundwork for its next phase.
The project will also benefit from the global expertise of Jones Lang LaSalle (JLL) and IQVIA, the consortium selected to undertake the feasibility study, bringing together specialist knowledge in life sciences, infrastructure development, investment advisory and healthcare strategy.
We look forward to the next steps.
@geraldmacharia, @FranKKeter_ @jpokwiri | #ApifaBiotech #Biopharma #LifeSciences #Parks #APIForAfrica
Apifa Biotech is establishing a pharmaceutical and life sciences manufacturing hub at #Konza Technopolis to support Kenya's efforts to strengthen #local #medicine #production, reduce reliance on pharmaceutical imports, and expand the country's participation in the regional healthcare manufacturing industry. | KBC TV Kenya. | Apifa Biotech, Chief Executive Officer, Dr Frankline Keter.
#ApifaBiotech #LocalProduction #EAC
Apifa Biotech moves to turn its vision of establishing Kenya’s first #Biopharma Life Sciences Park at Konza Technopolis into reality.
Structured as a public-private partnership (PPP) between Apifa Biotech and the @TechnopolisKE Development Authority, the project received approval in April 2026 to advance to the #development phase, marking a significant step towards establishing a world-class pharmaceutical and life sciences manufacturing hub in Kenya.
Today marks another major milestone, with Swedfund International, Sweden’s development finance institution, coming on board to support project preparation and feasibility studies for the proposed development. This funding commitment provides critical momentum to advance the project, strengthen its investment proposition and lay the groundwork for its next phase.
The project will also benefit from the global expertise of Jones Lang LaSalle (#JLL) and #IQVIA, the consortium selected to undertake the feasibility study, bringing together specialist knowledge in life sciences, infrastructure development, investment advisory and healthcare strategy.
Apifa Biotech remains committed to working alongside its partners to expand local production of essential medicines and active pharmaceutical ingredients (#APIs) across Africa through investment in research and development (R&D), the mobilization, structuring, and provision of financing to support pharmaceutical manufacturing, infrastructure development, and industrial capacity expansion across the continent.
@citizentvkenya @ntvkenya @devex
@HealthPolicyW @sarajerving @NationAfrica
@geraldmacharia, @FranKKeter_ , @apiforafrica | #ApifaBiotech #Biopharma #LifeSciences #Parks
Great possibilities require careful thought, strategic planning, and the right groundwork. Transformation is the product of vision, deliberate action, strong partnerships, and a shared commitment to creating possibilities that deliver lasting impact for generations to come.
Tomorrow, 12th November 2026, at JW Marriott, Nairobi, we step into a defining moment shaped by bold ambition, strategic partnerships, and the promise of a transformative future.
We are counting down the hours to an occasion poised to unlock new frontiers, accelerate innovation, and usher in a powerful new chapter for Kenya, the East African Community (EAC), and the entire African continent.
Watch this space. | @TechnopolisKE X @Swedfund
@ppp_kenya @apiforafrica @geraldmacharia @FranKKeter_ @jpokwiri | @NationAfrica @citizentvkenya @ntvkenya @StandardKenya @devex @HealthPolicyW
#ApifaBiotech #Biopharma #LifeSciencesPark
Apifa Biotech retweeted
It’s been a while, but let’s pick up where we left off.
#Recap: We’ve been exploring a critical question: Are existing financing mechanisms reaching local manufacturers on terms that are affordable and suited to their needs?
While significant #capital is available, the challenge is often how that capital reaches manufacturers, and whether the terms offered through existing channels are practical, affordable, and fit for purpose.
That’s the conversation we’re continuing.
What matters most to you as a manufacturer when accessing finance?
• Affordable interest rates and financing costs
• Flexible repayment terms that reflect cash-flow cycles
• Financing that matches the scale and stage of the business
• Faster, simpler access with less stringent requirements
#APIForAfrica | @apifabiotech
Apifa Biotech retweeted
Kenya Private Sector-Focused PPP Symposium 2026: The PPP Directorate showcases Kenya’s KES 1.1 Trillion Investment Portfolio
At today’s Kenya Private Sector-Focused PPP Symposium 2026, the PPP Director General, Eng. Kefa Seda, presented an update on Kenya’s growing PPP pipeline and reaffirmed Government’s commitment to creating a transparent, bankable and investor-friendly PPP ecosystem.
With 51 active projects valued at over KES 1.1 trillion across eight key sectors including roads and transport, agriculture, energy and power, housing, health, water and sanitation, urban development, and telecommunications - Kenya’s PPP programme continues to gain momentum. This growth is driven by stronger project preparation, enhanced investor protections under the PPP Act 2021, and deliberate efforts to de-risk projects and accelerate financial close.
His message to investors was clear: "Kenya is not asking investors to take a chance on the country; it is offering a structured, government-backed pipeline with a proven track record of delivery. The time to partner is now". @EngKefaSeda @SDPI_AM @KeTreasury @WorldBankKenya
#PPP2026 #InvestInKenya #PublicPrivatePartnerships #KenyaGrowth #PPP
Apifa Biotech retweeted
Konza Technopolis team, led by John Mbuthi, Acting Chief Manager, Research & Strategy, recently hosted a high-level consultative meeting with APIFA Biotech team, led by CEO Dr. Keter.
The discussions centered on the Biopharma Park Life Sciences Project; a transformative initiative currently under review by the National Treasury via a Public-Private Partnership (PPP) framework.
This collaboration marks a significant milestone in our mission to establish Konza Technopolis as Africa’s hub for life sciences, driving regional innovation in healthcare and biotechnology.
#SiliconSavannah – at Kabete, Kenya
At the Kenya International Investment Conference 2026, Apifa Biotech was highlighted as a key private-sector partner advancing the Life Sciences Park agenda. @apiforafrica @FranKKeter_ @ppp_kenya @kenyanwalstreet #KIICO2026 @geraldmacharia
kenyanwallstreet.com/kenya-l…
The @ppp_kenya Directorate called for increased private-sector financing to expedite the KSh 28.4 billion Life Sciences project, thereby accelerating implementation, de-risking delivery, and anchoring Kenya’s ambition to become a regional hub for pharmaceutical manufacturing.
As global health funding declines, dependence on a narrow set of manufacturers puts access at risk. New evidence shows why reforming development finance is essential to unlock sustainable, local production of medicines and diagnostics.
Learn more: journals.plos.org/globalpubl…
Unitaid is seeking qualified service providers to support our efforts to strengthen political commitment and public awareness for resource mobilization in prioritized countries. Submit your proposal by 20 March 2026, 17:00 CET.
Learn more: ungm.org/Public/Notice/29243…




























